Skip to main content
Enovis CORP logo

Enovis CORP — Investor Relations & Filings

Ticker · ENOV ISIN · US1940142052 LEI · 635400OP2DYYYMOIYL17 US Manufacturing
Open in API
Filings indexed 1,374 across all filing types
Latest filing 2019-11-06 Director's Dealing
Country US United States of America
Listing US ENOV

About Enovis CORP

https://www.enovis.com/

Enovis CORP is a global medical technology company focused on developing clinically differentiated solutions for musculoskeletal health. The company's portfolio addresses the continuum of care, from prevention and surgical intervention to rehabilitation. Its offerings include a wide range of products such as orthopedic bracing and supports, surgical implants for reconstructive joint surgeries, and technologies for bone growth stimulation and physical therapy. Through brands like DonJoy, Aircast, and Enovis Surgical, the company partners with healthcare professionals to improve patient outcomes and transform clinical workflows with its products, services, and integrated technologies.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2019-11-06 English
SC 13D/A Filing
Major Shareholding Notification
2019-11-01 English
8-K Filing
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated October 31, 2019, reporting the financial results for the third quarter ended September 27, 2019. It references a press release attached as Exhibit 99.1 that reports the financial results and mentions a scheduled conference call to discuss these results. The document itself is a current report announcing the earnings release and the conference call, not the full earnings report or transcript. The length is 3473 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as an Earnings Release (ER) announcement.
2019-10-31 English
10-Q Filing
Interim / Quarterly Report Q3 2019
2019-10-31 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes the completion of a divestiture transaction by Colfax Corporation, including details about the purchase agreement, transaction closing, and pro forma financial information. It also includes a press release and pro forma financials as exhibits. This type of filing is a regulatory announcement of a significant corporate event, specifically the completion of an acquisition or disposition of assets. It is not a full annual or quarterly report, nor is it a transcript, proxy, or other specialized filing. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2019-10-04 English
4 Filing
Director's Dealing
2019-10-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.